Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.57
+0.42 (2.08%)
Feb 6, 2026, 12:47 PM EST - Market open
Syndax Pharmaceuticals Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$80.23
Upside
+290.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $410 → $600 | Buy | Maintains | $410 → $600 | +2,816.87% | Jan 27, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +172.24% | Dec 9, 2025 |
| Barclays | Barclays | Buy Maintains $22 → $35 | Buy | Maintains | $22 → $35 | +70.15% | Nov 24, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $40 → $33 | Buy | Maintains | $40 → $33 | +60.43% | Nov 12, 2025 |
| UBS | UBS | Strong Buy Maintains $35 → $38 | Strong Buy | Maintains | $35 → $38 | +84.74% | Nov 4, 2025 |
| Barclays | Barclays | Buy Maintains $19 → $22 | Buy | Maintains | $19 → $22 | +6.95% | Nov 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +94.46% | Oct 27, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +172.24% | Oct 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +94.46% | Oct 16, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +172.24% | Sep 19, 2025 |
| Stifel | Stifel | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +113.90% | Sep 10, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $20 → $24 | Strong Buy | Maintains | $20 → $24 | +16.67% | Sep 5, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +65.29% | Sep 4, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $46 → $51 | Strong Buy | Maintains | $46 → $51 | +147.93% | Aug 5, 2025 |
| BTIG | BTIG | Strong Buy Maintains $43 → $56 | Strong Buy | Maintains | $43 → $56 | +172.24% | Aug 5, 2025 |
| UBS | UBS | Strong Buy Maintains $37 → $35 | Strong Buy | Maintains | $37 → $35 | +70.15% | Jul 15, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.